“With rapid pharmaceutical and technological development, it is nevertheless increasingly clear that universal access to (almost) free healthcare no longer can imply access to any healthcare.”
Jon Magnussen, PhD, Professor of Health Economics, Norwegian University of Science and Technology, Trondheim and University of Oslo

By Jon Magnussen, PhD, Professor of Health Economics at the Norwegian University of Science and Technology in Trondheim and at the University of Oslo